Fluindione is under investigation for the treatment of Venous Thrombosis, Pulmonary Embolism, Permanent Atrial Fibrillation, and Anticoagulating Treatment on a Duration at Least 12-month-old Superior. Fluindione has been investigated for the treatment of Blood Coagulation Disorders. It is grouped under the following drug class(es): Antithrombotic agents. Its therapeutic use is listed as anticoagulants and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Previscan, 2-(4-fluorophenyl)indene-1 and 3-dione. Its PubChem CID is 68942.
Fluindione
| CAS No | 957-56-2 |
|---|---|
| Molecular Formula | C15H9FO2 |
| Molecular Weight | 240.23 g/mol |
| Synonyms | 2-(4-fluorophenyl)indene-1,3-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Fluindione is under investigation for the treatment of Venous Thrombosis, Pulmonary Embolism, Permanent Atrial Fibrillation, and Anticoagulating Treatment on a Duration at Least 12-month-old Superior.
The listed CAS number is 957-56-2.
The listed molecular formula is C15H9FO2.
The listed molecular weight is 240.23 g/mol.
2-(4-fluorophenyl)indene-1,3-dione.
The source lists Previscan, 2-(4-fluorophenyl)indene-1 and 3-dione.